Skip to content

Trial Summary

A Study of MVC-101 (Also Known as TAK-186) in Adults With Advanced or Metastatic Cancer

Acronym:

TAK-186

ACTRN/NCT /ethics:

NCT04844073

Scientific title:

A Study of MVC-101 (Also Known as TAK-186) in Adults With Advanced or Metastatic Cancer

Sponsor / Cooperative group:

Takeda

Trial & Patient Characteristics

Cancer TypeAll cancers
Trial TypeTreatment
PhasePhase I; Phase II
Age Range18 years and older
SexAll
Tumour Stream -
Cancer StageLocally Advanced; Metastatic or Widespread
Anticipated Start Date2021-03-08
Anticipated End Date2024-10-01

Participating Hospitals

HospitalCancer Research SA
Clinical Trial CoordinatorKelly Mead
Emailadmin@cancerresearchsa.com.au
Phone08 8359 2565
Principal InvestigatorDr Ganessan Kichenadasse
Recruitment StatusRecruiting